1) thoracic stomach cancer

胸胃癌
1.
This study mainly investigated the clinical features of thoracic stomach cancer (TSC) after surgical treatment for esophageal carcinoma.
3%(17/51),弥漫侵润型较少见,占胸胃癌的3。
2) intrathoracic stomach

胸胃
1.
Surgical therapy for perforation of intrathoracic stomach after esophagogastrostomy;

食管胃吻合后胸胃瘘的外科治疗
2.
Objective The application of intrathoracic stomach fixation in esophageal bed with biological glue in order to decrease volume of intrathoracic stomach and improve pulmonary function of patients after operation.
目的应用生物胶将胸胃固定于纵隔食管床内,以减小胸胃的容积,改善患者术后肺功能。
3) Stomach cancer

胃癌
1.
Analysis of environmental geology and geochemistry features of high stomach cancer rate areas,Fujian Province;
福建省胃癌高发区环境地质、地球化学特征分析
2.
Clinical study on the effects of traditional Chinese medicine treatment on life quality improvement in elderly patients with advanced stomach cancer;
中医药治疗干预老年Ⅳ期胃癌患者生活质量的效果分析
3.
After stomach cancer technique chemotherapy common illness complication and its preventing and controlling;
胃癌术后化疗常见并发症及其防治
4) gastric cancer

胃癌
1.
Effect of mental intervention on psychological health of gastric cancer patients;

心理干预对胃癌患者心理健康状况的影响
2.
Bifidobacterium exopolysaccharide-loaded nanoparticles induces apoptosis of human gastric cancer cells transplanted into nude mice;
载双歧杆菌胞外多糖纳米粒子诱导人胃癌裸鼠移植瘤细胞的凋亡
3.
The clinical Significance of the diagnosis and preoperative staging of gastric cancer by the special scanning of multiple detector-row spiral computed tomography;
多排CT增强扫描对胃癌的临床意义
5) Gastric carcinoma

胃癌
1.
Expression and significance of Ang-2,VEGF and MVD in gastric carcinoma;

Ang-2、VEGF及MVD在胃癌中的表达及其临床意义
2.
Therapeutic effect of photodynamic therapy (PDT) in treatment of late-stage gastric carcinoma;
光动力学疗法关于治疗晚期胃癌的疗效
3.
Representation and significance of EZH2,Ki-67 in gastric carcinoma;

EZH2和Ki-67在胃癌中的表达及其临床意义
6) Carcinoma of stomach

胃癌
1.
Clinical study of early post-operative enteral nutritional support in patients with carcinoma of stomach;
胃癌术后早期肠内营养支持的临床分析
2.
Buprenorphine for use in PCIA or PCEA post radical operation for carcinoma of stomach.;

不同途径丁丙诺啡自控镇痛在胃癌术后的应用
3.
Telomerase activity in the carcinoma of stomach;

胃癌组织中端粒酶活性的检测及其意义
补充资料:乐得胃 ,乐得 ,乐胃,胃速乐
药物名称:乐得胃
英文名:Roter
别名: 乐得胃 ,乐得 ,乐胃,胃速乐
外文名:Roter
适应症: 用于治疗胃及十二指肠溃疡、胃炎、胃酸过多、神经性消化不良、胃灼热及痉挛等。国产的"乐胃"和胃速乐(weisrle)的组成、作用及用途与乐得胃相似。
用量用法:
口服:每次2片,每日3次,饭后嚼碎服,2~3个月为1疗程。疗程结束后,减低剂量,服维持量,每次1片,每日3次,连服2~3个月,其中可每日服1~3片。
注意事项:
服后无不良反应,服药期间大便呈黑色为正常现象。使用时忌食油腻食品和用餐过饱。胃酸缺乏者忌用。
规格: 片剂:每片含碱式硝酸铋0.3g,碳酸氢钠0.2g,碳酸镁0.4g,弗朗鼠李皮0.025g.
类别:制酸药和抗消化性溃疡药
英文名:Roter
别名: 乐得胃 ,乐得 ,乐胃,胃速乐
外文名:Roter
适应症: 用于治疗胃及十二指肠溃疡、胃炎、胃酸过多、神经性消化不良、胃灼热及痉挛等。国产的"乐胃"和胃速乐(weisrle)的组成、作用及用途与乐得胃相似。
用量用法:
口服:每次2片,每日3次,饭后嚼碎服,2~3个月为1疗程。疗程结束后,减低剂量,服维持量,每次1片,每日3次,连服2~3个月,其中可每日服1~3片。
注意事项:
服后无不良反应,服药期间大便呈黑色为正常现象。使用时忌食油腻食品和用餐过饱。胃酸缺乏者忌用。
规格: 片剂:每片含碱式硝酸铋0.3g,碳酸氢钠0.2g,碳酸镁0.4g,弗朗鼠李皮0.025g.
类别:制酸药和抗消化性溃疡药
说明:补充资料仅用于学习参考,请勿用于其它任何用途。
参考词条